Skip to main content
Erschienen in:

10.06.2024 | RESEARCH

Pulmonary function and bronchopulmonary dysplasia classification: insights from the Spanish Registry

verfasst von: Cristina Ramos-Navarro, Manuel Sánchez-Luna, Santiago Pérez-Tarazona, Ester Sanz-López, Elena Maderuelo-Rodriguez, Santiago Rueda-Esteban, Ana Sánchez-Torres, Ana Concheiro-Guisán, Manuel Sánchez-Solís, GEIDIS Research Network

Erschienen in: European Journal of Pediatrics | Ausgabe 9/2024

Einloggen, um Zugang zu erhalten

Abstract

In 2016, the Spanish Research Group on Bronchopulmonary Dysplasia (BPD) (GEIDIS) established a national registry with participation of 66 hospitals to collect information on clinical characteristics and long-term outcomes of BPD infants into adulthood. The aim of this observational study is to examine forced spirometry data in early childhood and to assess their correlation with the respiratory support required at 36 weeks postmenstrual age (PMA). The study analyzed data from preterm infants with BPD born between January 2016 and December 2017 who underwent forced spirometry at 5–7 years of age. Statistical analyses were conducted to investigate the relationships between spirometry results, perinatal factors, and the required respiratory support at 36 weeks PMA. The study involved 143 patients with a median gestational age (GA) of 27.3 weeks (range 25.7–28.7) and a median weight of 880 g (range 740–1135). Abnormal spirometry results were observed in 39.2% (56) of the patients. Among patients diagnosed with BPD type 3, those requiring over 30% oxygen at 36 weeks PMA exhibited an increased risk of abnormal spirometry results (OR 4.48; 95% CI 1.11–18.13) compared to those requiring positive pressure with less than 30% oxygen. In addition, this subgroup had a higher risk of developing a restrictive-mixed pattern compared to those with BPD type 1 (OR 10.65; 95% CI 2.06–54.98) and BPD type 2 (OR 6.76; 95% CI 1.09–42.06). No significant differences were found in the incidence of an obstructive pattern between BPD types.
     Conclusion: The requirement of more than 30% oxygen at 36 weeks PMA serves as a risk indicator for pulmonary function impairment in school-aged children with BPD. These findings suggest persistent airway and parenchymal injury in this specific patient population, and highlight the importance of careful monitoring to evaluate their long-term effects on lung function.
What is Known:
• Premature patients with bronchopulmonary dysplasia (BPD) may present abnormalities in pulmonary function tests during school age. However, the predictive accuracy of consensus BPD severity classification remains uncertain.
What is New:
• The requirement of more than 30% oxygen at 36 weeks postmenstrual age (PMA) indicates a potential risk of pulmonary function impairment in school-aged children with BPD. Additionally, a significant correlation has been observed between a restrictive-mixed pattern with exposure to mechanical ventilation and the development of severe forms of BPD.
Literatur
1.
Zurück zum Zitat Bui DS et al (2022) Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study. Lancet Respir Med 10(5):478–484CrossRefPubMed Bui DS et al (2022) Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study. Lancet Respir Med 10(5):478–484CrossRefPubMed
2.
Zurück zum Zitat Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729CrossRefPubMed Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729CrossRefPubMed
3.
4.
5.
Zurück zum Zitat Jensen EA et al (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach. Am J Respir Crit Care Med 200(6):751–759 Jensen EA et al (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach. Am J Respir Crit Care Med 200(6):751–759
6.
Zurück zum Zitat Higgins RD et al (2018) Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 197:300–308 Higgins RD et al (2018) Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 197:300–308
7.
Zurück zum Zitat Bancalari E, Jain D (2018) Bronchopulmonary dysplasia: can we agree on a definition? Am J Perinatol 35(6):537–540CrossRefPubMed Bancalari E, Jain D (2018) Bronchopulmonary dysplasia: can we agree on a definition? Am J Perinatol 35(6):537–540CrossRefPubMed
8.
Zurück zum Zitat Beydon N et al (2007) An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 175(12):1304–1345CrossRefPubMed Beydon N et al (2007) An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 175(12):1304–1345CrossRefPubMed
9.
Zurück zum Zitat Quanjer PH et al (2012) Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 40(6):1324–1343CrossRefPubMedPubMedCentral Quanjer PH et al (2012) Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 40(6):1324–1343CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Martín de Vicente C et al (2018) Validation of global lung function initiative and all ages reference equations for forced spirometry in healthy Spanish preschoolers. Arch Bronconeumol (Engl Ed) 54(1):24–30CrossRefPubMed Martín de Vicente C et al (2018) Validation of global lung function initiative and all ages reference equations for forced spirometry in healthy Spanish preschoolers. Arch Bronconeumol (Engl Ed) 54(1):24–30CrossRefPubMed
11.
Zurück zum Zitat Rite S et al (2022) The consensus definition of bronchopulmonary dysplasia is an adequate predictor of lung function at preschool age. Front Pediatr 10:830035CrossRefPubMedPubMedCentral Rite S et al (2022) The consensus definition of bronchopulmonary dysplasia is an adequate predictor of lung function at preschool age. Front Pediatr 10:830035CrossRefPubMedPubMedCentral
12.
13.
Zurück zum Zitat Fawke J et al (2010) Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 182(2):237–245CrossRefPubMedPubMedCentral Fawke J et al (2010) Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 182(2):237–245CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Doyle LW et al (2019) Expiratory airflow in late adolescence and early adulthood in individuals born very preterm or with very low birthweight compared with controls born at term or with normal birthweight: a meta-analysis of individual participant data. Lancet Respir Med 7(8):677–686CrossRefPubMed Doyle LW et al (2019) Expiratory airflow in late adolescence and early adulthood in individuals born very preterm or with very low birthweight compared with controls born at term or with normal birthweight: a meta-analysis of individual participant data. Lancet Respir Med 7(8):677–686CrossRefPubMed
15.
Zurück zum Zitat Ramos-Navarro C et al (2022) Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network. Eur J Pediatr 181(2):789–799CrossRefPubMed Ramos-Navarro C et al (2022) Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network. Eur J Pediatr 181(2):789–799CrossRefPubMed
16.
Zurück zum Zitat Jeon GW, Oh M, Chang YS (2021) Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network. Sci Rep 11(1):24349CrossRefPubMedPubMedCentral Jeon GW, Oh M, Chang YS (2021) Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network. Sci Rep 11(1):24349CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hurst JR et al (2020) Respiratory and cardiovascular outcomes in survivors of extremely preterm birth at 19 years. Am J Respir Crit Care Med 202(3):422–432CrossRefPubMedPubMedCentral Hurst JR et al (2020) Respiratory and cardiovascular outcomes in survivors of extremely preterm birth at 19 years. Am J Respir Crit Care Med 202(3):422–432CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Bårdsen T et al (2022) Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight. Thorax 77(8):790–798CrossRefPubMed Bårdsen T et al (2022) Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight. Thorax 77(8):790–798CrossRefPubMed
19.
Zurück zum Zitat Kotecha SJ et al (2013) Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 68(8):760–766CrossRefPubMed Kotecha SJ et al (2013) Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 68(8):760–766CrossRefPubMed
20.
Zurück zum Zitat Caskey S et al (2016) Structural and functional lung impairment in adult survivors of bronchopulmonary dysplasia. Ann Am Thorac Soc 13(8):1262–1270CrossRefPubMed Caskey S et al (2016) Structural and functional lung impairment in adult survivors of bronchopulmonary dysplasia. Ann Am Thorac Soc 13(8):1262–1270CrossRefPubMed
21.
Zurück zum Zitat Moschino L et al (2018) Longitudinal assessment of lung function in BPD survivors from birth to adulthood: the Padova BPD Study. Am J Respir Crit Care Med 198(1):134–137 Moschino L et al (2018) Longitudinal assessment of lung function in BPD survivors from birth to adulthood: the Padova BPD Study. Am J Respir Crit Care Med 198(1):134–137
22.
Zurück zum Zitat Broström EB et al (2010) Obstructive lung disease in children with mild to severe BPD. Respir Med 104(3):362–370CrossRefPubMed Broström EB et al (2010) Obstructive lung disease in children with mild to severe BPD. Respir Med 104(3):362–370CrossRefPubMed
24.
Zurück zum Zitat Vento M et al (2009) Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124(3):e439–e449CrossRefPubMed Vento M et al (2009) Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124(3):e439–e449CrossRefPubMed
25.
Zurück zum Zitat Gibbons JTD et al (2023) Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis. ERJ Open Res 9(3):00046–2023 Gibbons JTD et al (2023) Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis. ERJ Open Res 9(3):00046–2023
26.
Zurück zum Zitat McGinn EA et al (2023) Dysanapsis as a determinant of lung function in development and disease. Am J Respir Crit Care Med 208(9):956–963CrossRefPubMed McGinn EA et al (2023) Dysanapsis as a determinant of lung function in development and disease. Am J Respir Crit Care Med 208(9):956–963CrossRefPubMed
27.
Zurück zum Zitat Duke JW et al (2022) Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm. J Physiol 600(3):463–482CrossRefPubMed Duke JW et al (2022) Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm. J Physiol 600(3):463–482CrossRefPubMed
28.
Zurück zum Zitat Northway WH et al (1990) Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323(26):1793–1799CrossRefPubMed Northway WH et al (1990) Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323(26):1793–1799CrossRefPubMed
29.
Zurück zum Zitat Godfrey MS, Jankowich MD (2016) The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern. Chest 149(1):238–251CrossRefPubMed Godfrey MS, Jankowich MD (2016) The vital capacity is vital: epidemiology and clinical significance of the restrictive spirometry pattern. Chest 149(1):238–251CrossRefPubMed
30.
Zurück zum Zitat Dharmage SC et al (2023) Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study. Lancet Respir Med 11(3):273–282CrossRefPubMed Dharmage SC et al (2023) Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study. Lancet Respir Med 11(3):273–282CrossRefPubMed
31.
Zurück zum Zitat Pérez Tarazona S et al (2016) Guidelines for the follow up of patients with bronchopulmonary dysplasia. An Pediatr (Barc) 84(1):61.e1–9CrossRefPubMed Pérez Tarazona S et al (2016) Guidelines for the follow up of patients with bronchopulmonary dysplasia. An Pediatr (Barc) 84(1):61.e1–9CrossRefPubMed
Metadaten
Titel
Pulmonary function and bronchopulmonary dysplasia classification: insights from the Spanish Registry
verfasst von
Cristina Ramos-Navarro
Manuel Sánchez-Luna
Santiago Pérez-Tarazona
Ester Sanz-López
Elena Maderuelo-Rodriguez
Santiago Rueda-Esteban
Ana Sánchez-Torres
Ana Concheiro-Guisán
Manuel Sánchez-Solís
GEIDIS Research Network
Publikationsdatum
10.06.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 9/2024
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-024-05629-w

Neu im Fachgebiet Pädiatrie

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Kann man Gestationsdiabetes mit oralen Antidiabetika behandeln?

Der Wunsch, Frauen mit Gestationsdiabetes eine orale Erstlinientherapie anbieten zu können, bleibt auch vorläufig ein Wunsch: Eine orale Stufentherapie hat sich in einer randomisierten Studie nicht als gleichwertig zu einer Insulintherapie erwiesen. 

Frühwarnzeichen für multiple Sklerose bei Kindern und Jugendlichen

Ein Forschungsteam aus Deutschland und Kanada hat eine Reihe metabolischer, okulärer, muskuloskelettaler, gastrointestinaler und kardiovaskulärer Symptome identifiziert, die bei Kindern und Jugendlichen der Diagnose einer multiplen Sklerose (MS) vorausgehen können.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.